+49 (0)241 95 163 153
+49 (0)241 95 163 155


MMP9 Reaktivität: Human Colorimetric Sandwich ELISA 0.312-20 ng/mL Cell Culture Supernatant, Plasma, Serum, Tissue Homogenate, Urine
Produktnummer ABIN818177
  • Target Alle MMP 9 (MMP9) ELISA Kits anzeigen
    MMP 9 (MMP9) (Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase) (MMP9))
    • 13
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Sandwich ELISA
    0.312-20 ng/mL
    Untere Nachweisgrenze
    0.312 ng/mL
    For the quantitative determination of human matrix metalloproteinase 9/gelatinase B (MMP-9) concentrations in serum, plasma, tissue homogenates.
    Serum, Plasma, Tissue Homogenate, Cell Culture Supernatant, Urine
    Analytische Methode
    This assay has high sensitivity and excellent specificity for detection of human MMP-9.
    Kreuzreaktivität (Details)
    Limited by current skills and knowledge, it is impossible for us to complete the cross-reactivity detection between the target antigen and all analogues for other species. Therefore, cross reaction may still exist.
    0.284 ng/mL
    • Assay plate (12 × 8 coated Microwells)
    • Standard (freeze dried)
    • Biotin-antibody (100 × concentrate)
    • HRP-avidin (100 × concentrate)
    • Biotin-antibody Diluent
    • HRP-avidin Diluent
    • Sample Diluent
    • Wash Buffer (25 × concentrate)
    • TMB Substrate
    • Stop Solution
    • Adhesive Strip (for 96 wells)
    • Instruction manual
    Zu unserem meistverkauften MMP9 ELISA Kit
  • Applikationshinweise
    • The supplier is only responsible for the kit itself, but not for the samples consumed during the assay. The user should calculate the possible amount of the samples used in the whole test. Please reserve sufficient samples in advance.
    • Samples to be used within 5 days may be stored at 2-8°C, otherwise samples must be stored at -20°C (≤ 1 month) or -80°C (≤ 2 months) to avoid loss of bioactivity and contamination.
    • Grossly hemolyzed samples are not suitable for use in this assay.
    • If the samples are not indicated in the manual, a preliminary experiment to determine the validity of the kit is necessary.
    • Please predict the concentration before assaying. If values for these are not within the range of the standard curve, users must determine the optimal sample dilutions for their particular experiments.
    • Tissue or cell extraction samples prepared by chemical lysis buffer may cause unexpected ELISA results due to the impacts of certain chemicals.
    • Owing to the possibility of mismatching between antigens from another resource and antibodies used in this supplier's kits (e.g., antibody targets conformational epitope rather than linear epitope), some native or recombinant proteins from other manufacturers may not be recognized by this supplier's products.
    • Influenced by factors including cell viability, cell number and cell sampling time, samples from cell culture supernatant may not be recognized by the kit.
    • Fresh samples without long time storage are recommended for the test. Otherwise, protein degradation and denaturalization may occur in those samples and finally lead to wrong results.

    Detection wavelength: 450 nm

    Information on standard material:
    Depending on the antigen to be detected, standards can be either native or recombinant protein. The recombinant proteins are being expressed in CHO cells in most cases. Please inquire for more information. The formulation of auxiliary material in the standard is considered proprietary information, however it does not contain any poisonous substance. Proclin 300 (1:3000) is used as preservative.

    Information on reagents:
    In most cases the stop solution provided is 1 N H2SO4. The formulation of wash solution is proprietary information. None of the components contain (sodium) azide, thimerosal, 2-mercaptoethanol (2-ME) or any other poisonous materials. For the sandwich method kits, the sample diluent, antibody diluent, enzyme diluent and standard all contain BSA.

    Information on antibodies:
    The antibodies provided in different kits vary in regards to clonality and host. Some antibodies are affinity purified, some are Protein A

    100 μL
    1 - 4.5 h
    This assay employs the quantitative sandwich enzyme immunoassay technique. Antibody specific for MMP-9 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and any MMP-9 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for MMP-9 is added to the wells. After washing, avidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of MMP-9 bound in the initial step. The color development is stopped and the intensity of the color is measured.
    Aufbereitung der Reagenzien
    • Biotin-antibody (1×) - Centrifuge the vial before opening.
      Biotin-antibody requires a 100-fold dilution. The suggested dilution is 10µL of Biotin-antibody + 990µL of Biotin-antibody Diluent.
    • HRP-avidin (1×) - Centrifuge the vial before opening.
      HRP-avidin requires a 100-fold dilution. The suggested dilution is 10µL of HRP-avidin + 990µL of HRP-avidin Diluent.
    • Wash Buffer (1×) - If crystals have formed in the concentrate, warm up to room temperature and mix gently until the crystals have completely dissolved. Dilute 20mL of Wash Buffer Concentrate (25×) into deionized or distilled water to prepare 500mL of Wash Buffer (1×).
    • Standard - Centrifuge the standard vial at 6000-10000rpm for 30s.
      Reconstitute the Standard with 1ml of Sample Diluent. Do not substitute other diluents. This reconstitution produces a stock solution of 200pg/mL. Mix the standard to ensure complete reconstitution and allow the standard to sit for a minimum of 15 minutes with gentle agitation prior to making dilutions.
      Pipette 250µL of Sample Diluent into each tube. Use the stock solution to produce a 2-fold dilution series. Mix each tube thoroughly before the next transfer. The undiluted Standard serves as the high standard (200pg/mL). Sample Diluent serves as the zero standard (0ng/mL).
    • Kindly use graduated containers to prepare the reagent. Please don't prepare the reagent directly in the Diluent vials provided in the kit.
    • Bring all reagents to room temperature (18-25°C) before use for 30 min.
    • Prepare fresh standard for each assay. Use within 4 hours and discard after use.
    • Making serial dilution in the wells directly is not permitted.
    • Please carefully reconstitute Standards according to the instruction. Avoid foaming and mix gently until the crystals have completely dissolved. To minimize imprecision caused by pipetting, use small volumes and ensure that pipettors are calibrated. It is recommended to suck more than 10µL when pipetting.
    • It is recommended to use distilled water to prepare reagents and samples. Using contaminated water or container for reagent preparation will influence detection result.
    Intra-assay precision (precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess precision.
    Inter-assay precision (precision between assays): Three samples of known concentration were tested in twenty assays to assess precision.
    • Intra-assay: CV% less than 8%
    • Inter-assay: CV% less than 10%
    Nur für Forschungszwecke einsetzbar
  • Validierung #029586 (ELISA)
    'Independent Validation' Siegel
    Affina Biotechnologies
    Validierte Anwendung
    Human individual postmenopausal female serum
    Chicken plasma
    Signal was detected in positive control but not in negative control samples.
    'Independent Validation' Siegel
    • Antigen: human Matrix Metalloproteinase 9 (Gelatinase B, 92 kDa Gelatinase, 92 kDa Type IV Collagenase) (MMP9)
    • Catalog number: ABIN818177
    • Lot number: T23095910
    Full Protocol
    • 100 µL of standard and samples were added 96-well strip plates provided in the kit. All samples and standards were assayed in duplicate.
    • The microplate was covered and incubated at 37°C for 1 hr.
    • Plate contents were discarded.
    • 100 µL of biotin antibody conjugate was added and incubated at 37°C for 1 hr. - Content of the wells was discarded and wells were washed 3 times with 200 µL of 1x wash solution with a 2 min soak for each wash.
    • 100 µL of HRP-avidin conjugate was added and incubated at 37°C for 1 hr.
    • Contents of the wells were discarded and wells were washed 5 times with 200 µL of 1x wash solution with a 2 min soak for each wash.
    • 90 µL of TMB substrate was added to each well. The plate was covered and incubated at 37°C for 15 min.
    • 50 µL of the Stop Solution was added per well.
    • The optical density (OD value) of each well was read immediately using a microplate reader set to 450 nm.
    • The duplicate readings for each sample were averaged and the average zero standard optical density subtracted. The corrected average-value was tabulated as Average Absorbance. A standard curve was generated by plotting the mean OD value for each standard on the x-axis against the concentration on the Y-axis using CurveExpert 1.4. A linear equation was used for the best fit through the points on the graph.
    • The CurveExpert Analyze feature was used to calculate human MMP9 concentrations of the samples based on their Average Absorbance values.
    - Undiluted human serum produced artificially low concentration readings. 2-fold, 4-fold and 8-fold diluted samples showed essentially identical concentration readings.
  • Vorsichtsmaßnahmen
    The Stop Solution provided with this kit is an acid solution. Wear eye, hand, face and clothing protection when using this material.
    • The kit should not be used beyond the expiration date on the kit label.
    • Do not mix or substitute reagents with those from other lots or sources.
    • If samples generate values higher than the highest standard, dilute the samples with Sample Diluent and repeat the assay.
    • Any variation in Sample Diluent, operator, pipetting technique, washing technique, incubation time/temperature and kit age can cause variation in binding.
    • This assay is designed to eliminate interference by soluble receptors, binding proteins and other factors present in biological samples. Until all factors have been tested in the Immunoassay, the possibility of interference cannot be excluded.
    4 °C/-20 °C
    Informationen zur Lagerung
    For unopened kit: All the reagents should be kept according to the labels on vials.
    6 months
  • Scuruchi, DAscola, Avenoso, Zappone, Mandraffino, Campo, Campo: "miR9 inhibits 6-mer HA-induced cytokine production and apoptosis in human chondrocytes by reducing NF-kB activation." in: Archives of biochemistry and biophysics, Vol. 718, pp. 109139, (2022) (PubMed).

    Mehde, Mehdi, Yusof, Raus, Zainal Abidin, Ghazali, Abd Rahman: "Association of MMP-9 gene polymorphisms with nephrolithiasis patients." in: Journal of clinical laboratory analysis, Vol. 32, Issue 1, (2018) (PubMed).

    Sheikhvatan, Boroumand, Behmanesh, Ziaee: "Association of R279Q and C1562T polymorphisms of matrix metalloproteinase 9 gene and increased risk for myocardial infarction in patients with premature coronary artery disease." in: Journal of clinical laboratory analysis, Vol. 32, Issue 1, (2018) (PubMed).

    Jiao, He, Li, Fan, Si, Xie, Chang, Huang: "The Role of Circulating Tight Junction Proteins in Evaluating Blood Brain Barrier Disruption following Intracranial Hemorrhage." in: Disease markers, Vol. 2015, pp. 860120, (2016) (PubMed).

    Wang, Zhao, Liu, Wang, Liang, Cai, Zhang, Yang, Song, Li: "New application of an old drug: Antitumor activity and mechanisms of doxycycline in small cell lung cancer." in: International journal of oncology, Vol. 48, Issue 4, pp. 1353-60, (2016) (PubMed).

    Cheng, Wang, Dong, Pan, Wang, Han, Han, Yang: "Elevated serum brain natriuretic peptide and matrix metalloproteinases 2 and 9 in Wilson's disease." in: Metabolic brain disease, Vol. 30, Issue 4, pp. 1087-91, (2015) (PubMed).

    He, Li, Huang, Wang, Jiang, Chen, Su, Zhang, Wang: "Tumor Necrosis Factor-Alpha and 8-Hydroxy-2'-Deoxyguanosine are Associated with Elevated Urinary Angiopoietin-2 Level in Type 2 Diabetic Patients with Albuminuria." in: Kidney & blood pressure research, Vol. 40, Issue 4, pp. 355-65, (2015) (PubMed).

    Jain, Thanki, Jain: "Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part II in vivo pharmacokinetics, antitumor efficacy and hepatotoxicity." in: Pharmaceutical research, Vol. 31, Issue 4, pp. 946-58, (2014) (PubMed).

  • Target Alle MMP 9 (MMP9) ELISA Kits anzeigen
    MMP 9 (MMP9) (Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase) (MMP9))
    MMP9 Produkte
    CLG4B ELISA Kit, GELB ELISA Kit, MANDP2 ELISA Kit, MMP-9 ELISA Kit, AW743869 ELISA Kit, B/MMP9 ELISA Kit, Clg4b ELISA Kit, pro-MMP-9 ELISA Kit, mmp-9 ELISA Kit, fgMMP-9 ELISA Kit, mmp9 ELISA Kit, ZFMMP-9 ELISA Kit, wu:fb02g06 ELISA Kit, wu:fb07b05 ELISA Kit, wu:fi98c09 ELISA Kit, wu:fj05a08 ELISA Kit, zgc:64165 ELISA Kit, clg4b ELISA Kit, gelb ELISA Kit, mandp2 ELISA Kit, matrix metallopeptidase 9 ELISA Kit, collagenase ELISA Kit, matrix metalloproteinase 9 ELISA Kit, matrix metallopeptidase 9 S homeolog ELISA Kit, MMP9 ELISA Kit, RB3913 ELISA Kit, BPSS0666 ELISA Kit, Sbal_3732 ELISA Kit, Bcer98_0486 ELISA Kit, Shew185_0630 ELISA Kit, Shal_3056 ELISA Kit, Sbal195_0657 ELISA Kit, Lbys_3550 ELISA Kit, Palpr_2084 ELISA Kit, Mmp9 ELISA Kit, mmp9 ELISA Kit, mmp9.S ELISA Kit
    Synonyms: CLG4B, GELB, MANDP2, MMP-9, macrophage gelatinase|matrix metalloproteinase 9|matrix metalloproteinase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase)|type V collagenase
    Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, CXCR4-mediated Signaling Events
Sie sind hier: